Acerus Pharmaceuticals Corporation entered into an amended agreement related to its existing credit facility with SWK Funding LLC, a subsidiary of SWK Holdings Corporation.The nature of the amendments are to: i) set principal repayment at US$1.1...
Read Story
March 26, 2021, 07:57 AM
|
pSivida Corp., a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, announced the acquisition of Icon Bioscience Inc. (Icon). Icon is a specialty biopharmaceutical company whose lead...
Read Story
April 02, 2018, 07:10 AM
|